Max Healthcare Institute Limited (MAXHEALTH) — Annual Report

1 Annual Report 🔴 High Importance Neutral 📄 PDF

📢 Key Event
Max Healthcare releases FY2025-26 BRSR report emphasizing sustainable healthcare and governance.

💡 Investor Takeaway
The company prioritizes sustainable growth and patient-centric care, with strong ESG integration and no material financial shifts reported.

Max Healthcare Institute Limited’s FY 2025-26 Business Responsibility and Sustainability Report underscores its commitment to compassionate care, sustainable growth, and responsible governance. The consolidated report highlights 98.23% revenue from healthcare services, 86% sustainable sourcing, 55% renewable electricity use, and 90% waste diversion from landfills. Key initiatives include renewable energy adoption, water recycling (52% reuse), and ESG risk management. Governance is overseen by the Board and ESG Committee, with TÜV SÜD providing limited assurance on disclosures. No material financial changes or forward guidance were specified, though risks like climate impacts and supply chain vulnerabilities are noted. The company emphasizes patient safety, data privacy, and inclusive growth, aligning with UN SDGs and SEBI regulations.

2 Annual Report 🔴 High Importance Neutral 📄 PDF

📢 Key Event
25th Annual General Meeting (AGM) of Max Healthcare Institute Limited scheduled for July 30, 2026, via video conference to consider financial statements, dividend declaration, director re-appointments, and remuneration approvals.

🔄 What Changed
Re-appointment of Mr. Anil Kumar Bhatnagar as Non-Executive Director for a three-year term (Oct 1, 2026 - Sep 30, 2029) with proposed remuneration increase from ₹35 lakh to ₹40 lakh per annum; approval of non-executive director remuneration; shift of registered office from Maharashtra to Haryana; ratification of cost auditor remuneration of ₹10,42,000 for FY 2026-27.

🔮 What's Next
The company proposes shifting its registered office from Maharashtra to Haryana to align with operational hubs in Gurugram, citing strategic, administrative, and efficiency benefits. It also recommends approval of non-executive director remuneration at ₹40 lakh per annum effective October 1, 2026, up from ₹35 lakh, within regulatory limits.

💡 Investor Takeaway
Shareholders must approve director re-appointments and remuneration, and the company is relocating its registered office to Haryana to support growth in North India operations.

The 25th Annual General Meeting (AGM) of Max Healthcare Institute Limited is scheduled for July 30, 2026, at 10:30 am IST via video conference. Shareholders will vote on key resolutions including adoption of financial statements, declaration of a final dividend of ₹2 per share (record date July 3, 2026), re-appointment of directors, and approval of remuneration for non-executive directors. The meeting will be conducted electronically with no physical attendance or proxy voting; quorum will be based on electronic attendance. Shareholders can participate through the InstaVote platform, with specific instructions for demat and physical share holders. The filing also includes details on registrar and share transfer agent, E-voting timelines (July 27-29, 2026), and procedures for dividend claims and unclaimed dividend transfers.

📊 Stock Analysis — MAXHEALTH ✨ Ask AI About This